Strategic Deployment

TSH Biopharm is dedicating to medicines development and innovation in chronic diseases field and continue developing other related health products, especially focusing on cardiovascular, gastrointestinal, and autoimmune diseases. Through self-development and co-development products, TSH biopharm will keep providing economic treatment plan to gain more welfare for chronic patients.


 l   Company strategy

 To integrate pharmaceuticals value chain by self-development and co-development and building patent portfolio and targeting Asia market.


l   Marketing strategy

 Taiwan as TSH’s home base to explore chronic diseases in Asia pharmaceutical market by high barrier product and patent obtained.


l   Product developed strategy

 Focused on developing cardiovascular, gastrointestinal, and autoimmune products through co-development and self-development.



Business Development & Licensing

Cardiovascular, gastrointestinal, and autoimmune fields are our focus categories.
We welcome different business collaboration and our goal is to create long-term mutually beneficial relationships with our partners. We are committed to partnerships that help speed up market access of innovative new medicines within our therapy area portfolio. We believe that by working together with you we can play a major role in transforming health care. If your products are in our target fields or you are interested in marketing our products, please contact as at